Disease Info Card

Neonatal Hepatitis

Information about Neonatal Hepatitis: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Neonatal Hepatitis

Most recent studies have shown that Neonatal Hepatitis shares some biological mechanisms with alpha-1-antitrypsin-deficiency, atresia, autoimmune-reaction, biliary-atresia, choledochal-cyst, cholestasis, cytomegalovirus-infections, fibrosis, hepatitis, hepatitis-a, hepatitis-b, icterus, intrahepatic-cholestasis, jaundice-obstructive, liver-cirrhosis, liver-diseases, liver-failure, neonatal-cholestasis, neonatal-jaundice, virus-diseases.

Among the many pathways, these few ones have gauged particular interests from scientists studying Neonatal Hepatitis, and have been seen in publications frequently: Angiogenesis, Cell Proliferation, Cholesterol Esterification, Coagulation, Cytokine Secretion, Excretion, Hypersensitivity, Immune Response, Inflammatory Response, Intestinal Absorption, Liver Development, Localization, Malate-aspartate Shuttle, Pathogenesis, Pigmentation, Protein Unfolding, Proteolysis, Secretion, Sensitization, Urea Cycle

Quite a number of genes have been found to play important roles in Neonatal Hepatitis, such as AFP, ALB, CYP27A1, F2, GGT1, GGT2, GGTLC1, GSTP1, IL2, IL6, KRT7, LTA, POMC, SERPINA1, SLC25A13, TNF, TRIM26. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.